Global Transcatheter Embolization and Occlusion Devices Market

Transcatheter Embolization and Occlusion Devices Market Size, Share, Growth Analysis, By Type(Coil [Pushable Coils, Detachable Coils], Non-Coil [Flow Diverting Devices, Embolization Particles), By Application(Peripheral Vascular Disease [Arterial Blockage, Venous Blood clot, Others], Oncology [Liver Cancer), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35A2295 | Region: Global | Published Date: October, 2024
Pages: 157 | Tables: 66 | Figures: 75

Transcatheter Embolization and Occlusion Devices Market Competitive Landscape

The global transcatheter embolization and occlusion devices market is highly competitive and characterised by the presence of several major players. These companies are engaged in continuous research and development activities to introduce innovative products and gain a competitive edge in the market. The competitive landscape is shaped by factors such as product offerings, technological advancements, strategic collaborations, and geographical presence.

Top Player’s Company Profiles

  • Boston Scientific Corporation (US) 
  • Terumo Corporation (Japan) 
  • Medtronic (Ireland) 
  • Abbott (US)  
  • Cook Medical Inc. (US) 
  • Penumbra, Inc. (US) 
  • Cerenovus (a subsidiary of Johnson & Johnson) (US) 
  • Guerbet S.A. (France) 
  • Merit Medical Systems, Inc. (US) 
  • AngioDynamics, Inc. (US) 
  • B. Braun Melsungen AG (Germany) 
  • Humares (Germany) 
  • Inari Medical, Inc. (US) 
  • MicroVention, Inc. (US) 
  • Endospan Ltd. (Israel) 
  • Teleflex Incorporated (US) 
  • Kaneka Corporation (Japan) 
  • Abbott Vascular (a division of Abbott Laboratories) (US) 
  • SentreHEART, Inc. (US) 
  • Vascular Technologies (US)

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Transcatheter Embolization and Occlusion Devices Market size was valued at USD 4.5 billion in 2022 and is poised to grow from USD 4.82 billion in 2023 to USD 8.41 billion by 2031, growing at a CAGR of 7.20% during the forecast period (2024-2031).

The global transcatheter embolization and occlusion devices market is highly competitive and characterised by the presence of several major players. These companies are engaged in continuous research and development activities to introduce innovative products and gain a competitive edge in the market. The competitive landscape is shaped by factors such as product offerings, technological advancements, strategic collaborations, and geographical presence. 'Boston Scientific Corporation (US) ', 'Terumo Corporation (Japan) ', 'Medtronic (Ireland) ', 'Abbott (US)  ', 'Cook Medical Inc. (US) ', 'Penumbra, Inc. (US) ', 'Cerenovus (a subsidiary of Johnson & Johnson) (US) ', 'Guerbet S.A. (France) ', 'Merit Medical Systems, Inc. (US) ', 'AngioDynamics, Inc. (US) ', 'B. Braun Melsungen AG (Germany) ', 'Humares (Germany) ', 'Inari Medical, Inc. (US) ', 'MicroVention, Inc. (US) ', 'Endospan Ltd. (Israel) ', 'Teleflex Incorporated (US) ', 'Kaneka Corporation (Japan) ', 'Abbott Vascular (a division of Abbott Laboratories) (US) ', 'SentreHEART, Inc. (US) ', 'Vascular Technologies (US)'

The global market for transcatheter embolization and occlusion devices is witnessing growth due to the rising demand for minimally invasive treatment options. Patients and medical professionals are increasingly opting for these procedures because they offer benefits such as faster recovery times, shorter hospital stays, and reduced risk of complications. The preference for minimally invasive procedures is a major driver behind the increasing demand for transcatheter embolization and occlusion devices.

Adoption of New Technologies: New technologies are being developed that offer improved safety and efficacy, and these new technologies are expected to drive market growth in the coming years. In addition to the increasing adoption of new technologies, other key market trends for transcatheter embolization and occlusion devices include the increasing prevalence of chronic diseases, the rising demand for minimally invasive procedures, and the increasing adoption of reimbursement policies for these devices. As the market continues to grow, we can expect to see more innovation in the transcatheter embolization and occlusion devices industry, and this innovation is expected to help these devices become even more effective in treating a variety of medical conditions.

North America has emerged as the most dominant market for transcatheter embolization and occlusion devices. This can be attributed to the well-established healthcare infrastructure, high adoption rate of advanced medical technologies, and favourable reimbursement policies in countries like the United States and Canada. The presence of key market players and ongoing research and development activities in the region further contribute to its dominance.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Transcatheter Devices Market
Buy Now GET FREE SAMPLE
Angiographic Catheters Market
Buy Now GET FREE SAMPLE
Neurovascular Catheters Market
Buy Now GET FREE SAMPLE
Catheter Market
Buy Now GET FREE SAMPLE
Foley Catheter Market
Buy Now GET FREE SAMPLE
Catheter Securement Device Market
Buy Now GET FREE SAMPLE
Urinary Catheters Market
Buy Now GET FREE SAMPLE
Occlusion Devices Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Transcatheter Embolization and Occlusion Devices Market

Report ID: SQMIG35A2295

$5,300
BUY NOW GET FREE SAMPLE